Changes in cardiovascular risk factors in a type 1 diabetes population: A 3.5-year study

Practical Diabetes International

Volumn 25, Issue 6, 2008, Pages 223-227

  Wallymahmed, Maureen E ^a   Morgan, C ^a   Gill, G V ^a   Osman Hicks, V ^a   Chamberlain, P ^a   MacFarlane, I A ^a  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Blood pressure; Glycated haemoglobin; Lipid profile; Type 1 diabetes; Vascular risk factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE DURATION; DRUG USE; EXERCISE; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; POPULATION RESEARCH; PREVALENCE; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

EID: 54849415498     PISSN: 13578170     EISSN: 1528252X     Source Type: Journal    
DOI: 10.1002/pdi.1258     Document Type: Article

References (15)

1. Laing SP, Swerdlow AJ, Slater SD, et al. The British Diabetic Association Cohort Study, II: cause-specific mortality in patients with insulin treated diabetes mellitus. Diabetic Med 1999; 16: 466-471.
2. Pambianco G, Costacou T, Ellis D, et al. The Pittsburgh epidemiology of diabetes complications study experience. Diabetes 2006; 55: 1463-1469.
3. Soedamah-Muthu SS, Fuller JH, Mulnier HE, et al. All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general research database, 1992-1999. Diabetologia 2006; 49: 660-666.
4. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
5. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with Type 1 diabetes. N Engl J Med 2005; 353: 2643-2653.
6. European Diabetes Policy Group. A desktop guide to type 1 (insulin dependent) diabetes mellitus. Diabetic Med 1999; 16: 253-256.
7. National Institute for Health and Clinical Excellence. Type 1 diabetes: National clinical guidance for diagnosis and management in primary care. London: National Institute for Health and Clinical Excellence, 2004.
8. Joint British Societies. JBS 2: Joint British Societies Guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005; 91(Suppl 5): v1-v52.
9. Wallymahmed ME, Pinkney J, Saunders S, et al. Vascular risk factors in patients with type 1 diabetes. Pract Diabetes Int 2005; 22: 81-85.
10. Jacobs ML, Elte JWF, van Ouwerkerk BM, et al. Effect of BMI, insulin dose and number of injections on glycaemic control in insulin-using diabetic patients. Netherlands J Med 1997; 50: 153-159.
11. Resnick HE, Bardsley J, Foster GL, et al. Achievement of American Diabetes Association clinical practice recommendations among U.S. adults with diabetes, 1999-2002. Diabetes Care 2006; 29: 531-537.
12. Coppell KJ, Anderson K, Williams S, et al. Evaluation of diabetes care in the Otago region using a diabetes register, 1998-2003. Diabetes Res Clin Pract 2006; 71: 345-352.
13. Eeg-Olofsson K, Cederholm J, Nilsson PM, et al. Glycemic and risk factor control in Type 1 diabetes. Diabetes Care 2007; 30: 496-502.
14. Joseph F, Younis N, Sowery J, et al. Blood pressure control in diabetes: are we achieving the guideline targets? Pract Diabetes Int 2003; 20: 276-282.
15. Zgibor JC, Wilson RR, Orchard TJ. Has control of hypercholesterolemia and hypertension in type 1 diabetes improved over time? Diabetes Care 2005; 28: 521-526.